Wilms Tumor — Trials · CancerIndex

Clinical trials

Registered studies

106 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 31
Recruiting: 17
Ph III recruiting: 1
Growth YoY: —
Industry share: 0%
Top sponsor: National Cancer Institute (NCI)
Termination share: 24.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (9)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06873672	Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China	not yet recruiting	—	360	RenJi HospitalOTHER	1	Mar 13, 2025	clinicaltrials
NCT03892330	Combination Therapy of Anthracyclines for Children With Nephroblastoma	not yet recruiting	Phase 4	120	Shengjing HospitalOTHER	1	Mar 27, 2019	clinicaltrials